- Home
- PXLW vs SRZN Comparison
PXLW vs SRZN Comparison
Compare PXLW & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PXLW
- SRZN
- Stock Information
- Founded
- PXLW 1997
- SRZN 2015
- Country
- PXLW United States
- SRZN United States
- Employees
- PXLW N/A
- SRZN N/A
- Industry
- PXLW Semiconductors
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- PXLW Technology
- SRZN Health Care
- Exchange
- PXLW Nasdaq
- SRZN Nasdaq
- Market Cap
- PXLW 41.8M
- SRZN 38.1M
- IPO Year
- PXLW 2000
- SRZN N/A
- Fundamental
- Price
- PXLW $0.73
- SRZN $9.72
- Analyst Decision
- PXLW Strong Buy
- SRZN
- Analyst Count
- PXLW 3
- SRZN 0
- Target Price
- PXLW $2.17
- SRZN N/A
- AVG Volume (30 Days)
- PXLW 279.1K
- SRZN 48.5K
- Earning Date
- PXLW 02-06-2025
- SRZN 11-06-2024
- Dividend Yield
- PXLW N/A
- SRZN N/A
- EPS Growth
- PXLW N/A
- SRZN N/A
- EPS
- PXLW N/A
- SRZN N/A
- Revenue
- PXLW $54,190,000.00
- SRZN $10,000,000.00
- Revenue This Year
- PXLW N/A
- SRZN N/A
- Revenue Next Year
- PXLW $18.92
- SRZN N/A
- P/E Ratio
- PXLW N/A
- SRZN N/A
- Revenue Growth
- PXLW N/A
- SRZN N/A
- 52 Week Low
- PXLW $0.61
- SRZN $6.00
- 52 Week High
- PXLW $3.08
- SRZN $16.19
- Technical
- Relative Strength Index (RSI)
- PXLW 48.37
- SRZN 47.50
- Support Level
- PXLW $0.72
- SRZN $9.20
- Resistance Level
- PXLW $0.86
- SRZN $11.06
- Average True Range (ATR)
- PXLW 0.04
- SRZN 1.19
- MACD
- PXLW -0.01
- SRZN -0.06
- Stochastic Oscillator
- PXLW 30.50
- SRZN 14.13
About PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in China.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).